NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. SIFROL ER CMI0120-08 extended-release tablets pramipexole dihydrochloride
Continue reading »
APO-Ramipril Capsules
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-RAMIPRIL contains the active ingredient ramipril Consumer
Continue reading »DermAid Cream
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. EGO DERMAID 1% CREAM Hydrocortisone 1 %
Continue reading »APO-Olmesartan
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-OLMESARTAN Contains the active ingredient olmesartan medoxomil
Continue reading »APO-Pravastatin
NOTICE: This Consumer Medicine Information (CMI) is intended for persons living in Australia. APO-PRAVASTATIN TABLETS Contains the active ingredient pravastatin
Continue reading »Naltrexone use decreases the risk of hospitalization in persons with alcohol use disorder
Naltrexone, used either alone or together with disulfiram or acamprosate, is associated with a decreased risk of hospitalization due to
Continue reading »Increase in pleasurable effects of alcohol over time can predict alcohol use disorder
A new study out of the University of Chicago Medicine following young adult drinkers for 10 years has found that
Continue reading »Alcohol consumption impairs visual function and adversely affects driving performance
A study carried out by researchers from the Department of Optics of the University of Granada (UGR) has revealed that
Continue reading »New form of brain-training helps prevent relapse after alcohol treatment
A recent study has shown that it may be possible to dampen the workings of the subconscious brain to prevent
Continue reading »Your in-laws’ history of drinking problems could lead to alcohol issues of your own
The statistics are sobering. More than 14 million American adults suffer from some form of alcohol use disorder (AUD), a
Continue reading »